Viatris Healthcare Pty Limited Pharmaceutical Import Profile — South Africa (DGFT 2022–2026)

Name: Viatris Healthcare Pty Limited Pharmaceutical Import Records from India — 4 Products, $1.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Viatris Healthcare Pty Limited — Pharmaceutical Importer Profile (2026) | 4 Products, $1.9M Trade | TransData Nexus

Viatris Healthcare Pty Limited

Pharmaceutical Importer · South Africa · Antiviral & HIV Medications Focus · $1.9M Total Trade · DGFT Verified

Viatris Healthcare Pty Limited is a pharmaceutical importer based in South Africa with a total trade value of $1.9M across 4 products in 3 therapeutic categories. Based on 39 verified import shipments from Indian Customs (DGFT) records, Viatris Healthcare Pty Limited is the #1 buyer in 2 products including Emtricitabine, Efavirenz. Viatris Healthcare Pty Limited sources from 3 verified Indian suppliers, with Mylan Laboratories Limited accounting for 86.5% of imports.

Viatris Healthcare Pty Limited — Import Portfolio & Supplier Network

Viatris Healthcare Pty Limited import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Viatris Healthcare Pty Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Mylan Laboratories Limited	$2.6M	58	86.5%
Qualigens Pharma Private Limited	$258.6K	9	8.6%
Granules India Limited

What Formulations Does Viatris Healthcare Pty Limited Import?

Formulation	Value	Ships
Acriptega tenofovirdisoproxilfumarate	$700.0K	14
Rilovia lopinavir 200 MG +	$350.0K	7
Dumiva abacavir sulfate 600MG +	$250.0K	5
Pharmaceutical goods/ harmless medicines- metformin tablets BP 500MG Each filmcoated tablet contains metformin	$122.9K	4
Efavirenz 200 MG tablets 84's	$100.0K	2
Tenemine tenofovir disoproxil fumarate300 MG+ emtricitabine 200 MG TAB 28s 62922 packs x 28s = 1761816	$100.0K	2
Myltega dolutegravir TAB 50MG	$100.0K	2
Mylan metformin 850MG 60s mylan metformin 850MG 60s 70080	$97.0K	2
Pharmaceutical goods/ harmless medicines- diclofenac sodium 50MG tablets eachenteric coated tablet contains	$77.8K	2
Dolutegravir dt 10MG	$61.8K	2
Eflaten tenofovirdisoproxilfumarate300m	$50.0K	1
Lopinavir 100MG + ritonavir 25MG	$50.0K	1
Efrin TAB 28's efavirenz 600 MG	$50.0K	1
Dovprela pretomanid TAB 200MG 26s TAB	$50.0K	1
Tenemine 30'stenofovirdisoproxilfumarat	$50.0K	1

Viatris Healthcare Pty Limited imports 37 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Tenofovir	Antiviral & HIV Medications	$650.0K	13	0.0%	9
2	Emtricitabine	Antiviral & HIV Medications	$600.0K	12	0.5%	1
3	Efavirenz	Antivirals	$550.0K	11	0.7%	1
4	Proguanil	Antimalarial & Antiparasitic	$121.1K	3	0.0%	13

Viatris Healthcare Pty Limited imports 4 pharmaceutical products across 3 categories into South Africa totaling $1.9M. The company is the #1 buyer for 2 products: Emtricitabine, Efavirenz.

Viatris Healthcare Pty Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Viatris Healthcare Pty Limited is a pharmaceutical importer and distributor based in South Africa, operating as a subsidiary of Viatris Inc., a global healthcare company formed in 2020 through the merger of Mylan and Upjohn, a legacy division of Pfizer. (viatris.co.za) The company is headquartered at 4 Brewery Street, Isando, Kempton Park, Gauteng, 1601, South Africa. (pi-pil-repository.sahpra.org.za) Viatris Healthcare Pty Limited plays a pivotal role in the South African pharmaceutical distribution network by importing and distributing a diverse range of high-quality medicines, thereby enhancing access to essential healthcare products across the country.

2Distribution Network

Viatris Healthcare Pty Limited's distribution network is strategically located to serve the South African market effectively. The company's primary facility is situated at 4 Brewery Street, Isando, Kempton Park, Gauteng, 1601, South Africa. (pi-pil-repository.sahpra.org.za) While specific details regarding additional warehouse locations and logistics capabilities are not publicly disclosed, the company's affiliation with Viatris Inc. suggests access to a robust global supply chain infrastructure. This infrastructure likely supports efficient distribution within South Africa and potentially to neighboring regions, ensuring timely delivery of pharmaceutical products to meet local demand.

3Industry Role

In the South African pharmaceutical supply chain, Viatris Healthcare Pty Limited functions as a primary wholesaler and distributor. The company imports finished pharmaceutical formulations from various international suppliers, including Indian manufacturers, and distributes these products to local healthcare providers, pharmacies, and hospitals. By acting as an intermediary between international manufacturers and the South African market, Viatris Healthcare Pty Limited ensures the availability of a wide range of medicines, thereby contributing to the country's healthcare system.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Viatris Healthcare Pty Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Viatris Healthcare Pty Limited's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical imports originating from India. Between 2022 and 2026, the company imported finished pharmaceutical formulations totaling $1.9 million USD across 39 shipments, with the top five products accounting for 100% of the import value. The primary suppliers from India include Mylan Laboratories Limited, Qualigens Pharma Private Limited, and Granules India Limited. This concentrated sourcing approach may offer benefits such as streamlined procurement processes and potential cost efficiencies. However, it also introduces risks related to supply chain disruptions, currency fluctuations, and geopolitical factors that could impact the stability and reliability of the supply chain.

2Supply Chain Resilience

The resilience of Viatris Healthcare Pty Limited's supply chain is closely tied to its reliance on a limited number of Indian suppliers. While this focused sourcing strategy may enhance operational efficiency, it also exposes the company to potential vulnerabilities. For instance, any disruptions affecting these suppliers—such as production delays, regulatory changes, or logistical challenges—could significantly impact the availability of imported pharmaceutical products. To mitigate these risks, it is advisable for Viatris Healthcare Pty Limited to diversify its supplier base and establish contingency plans, including identifying alternative suppliers and maintaining strategic stock levels. Additionally, ensuring that all suppliers adhere to recognized Good Manufacturing Practices (GMP) and comply with South African regulatory standards is crucial for maintaining product quality and supply chain integrity.

Importing Pharmaceuticals into South Africa — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for South Africa

1Regulatory Authority & Framework

The South African Health Products Regulatory Authority (SAHPRA) is the primary body responsible for regulating the importation, registration, and distribution of pharmaceutical products in South Africa. Operating under the Medicines and Related Substances Act 101 of 1965, as amended, SAHPRA ensures that all medicines meet the required standards of safety, efficacy, and quality before they are made available to the public. The regulatory framework encompasses various aspects, including the licensing of manufacturers, wholesalers, and distributors, as well as the approval of marketing authorizations for pharmaceutical products. This comprehensive oversight aims to safeguard public health by ensuring that all pharmaceutical products in the market are both effective and safe for consumer use. (sahpra.org.za)

2Import Licensing & GMP

To import pharmaceutical products into South Africa, companies must obtain the necessary licenses from SAHPRA. This includes a wholesaler's license authorizing the importation and distribution of medicines. Additionally, the South African Pharmacy Council requires that pharmaceutical manufacturers and wholesalers be licensed and recorded as a manufacturing or wholesale pharmacy, with a dedicated responsible pharmacist overseeing operations. Compliance with Good Manufacturing Practices (GMP) is mandatory, ensuring that all imported medicines meet the required standards of quality and safety. Recognized GMP certifications include those from the European Union (EU GMP), the World Health Organization (WHO GMP), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications are essential for maintaining the integrity of the pharmaceutical supply chain and ensuring that imported products are safe for consumer use.

Viatris Healthcare Pty Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Viatris Healthcare Pty Limited's product strategy focuses on importing and distributing a range of pharmaceutical formulations across three therapeutic categories: Antiviral & HIV Medications, Antivirals, and Antimalarial & Antiparasitic agents. The company's top five imported products include Emtricitabine, Efavirenz, Tenofovir, Proguanil, and Lamivudine, with Emtricitabine and Efavirenz being the leading products in their respective categories. This strategic focus aligns with the significant demand for HIV and antimalarial treatments in South Africa, addressing critical public health needs. By concentrating on these therapeutic areas, Viatris Healthcare Pty Limited aims to provide essential medicines that improve patient outcomes and contribute to the country's healthcare objectives.

2Sourcing Profile

Viatris Healthcare Pty Limited's sourcing strategy is centered on importing finished pharmaceutical formulations from a select group of Indian manufacturers, including Mylan Laboratories Limited, Qualigens Pharma Private Limited, and Granules India Limited. This approach allows the company to leverage established relationships and ensure a consistent supply of high-quality medicines. The focus on finished formulations, rather than raw active pharmaceutical ingredients (APIs), indicates a preference for ready-to-market products that meet the specific regulatory and quality standards required in South Africa. India's robust pharmaceutical manufacturing sector, with its adherence to international GMP standards, makes it a strategic partner for Viatris Healthcare Pty Limited in fulfilling the diverse healthcare needs of the South African market.

Seller's Guide — How to Become a Supplier to Viatris Healthcare Pty Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Viatris Healthcare Pty Limited, particularly if they can offer high-quality finished pharmaceutical formulations that align with the company's therapeutic focus areas. To identify potential gaps in Viatris Healthcare Pty Limited's current sourcing, a detailed analysis of the company's existing product

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Viatris Healthcare Pty Limited

What products does Viatris Healthcare Pty Limited import from India?

Viatris Healthcare Pty Limited imports 4 pharmaceutical products across 3 categories. Top imports: Tenofovir ($650.0K), Emtricitabine ($600.0K), Efavirenz ($550.0K), Proguanil ($121.1K).

Who supplies pharmaceuticals to Viatris Healthcare Pty Limited from India?

Viatris Healthcare Pty Limited sources from 3 verified Indian suppliers. The primary supplier is Mylan Laboratories Limited (86.5% of imports, $2.6M).

What is Viatris Healthcare Pty Limited's total pharmaceutical import value?

Viatris Healthcare Pty Limited's total pharmaceutical import value from India is $1.9M, based on 39 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Viatris Healthcare Pty Limited focus on?

Viatris Healthcare Pty Limited imports across 3 categories. The largest: Antiviral & HIV Medications (65.1%), Antivirals (28.6%), Antimalarial & Antiparasitic (6.3%).

Get Full Viatris Healthcare Pty Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.